Clincosm LogoSign in Get a demo

liver fibrosis

Showing 26 - 50 of 122
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Development and Validation of Point-of-Care Diagnostic Liver

Recruiting
  • Liver Diseases
  • +3 more
  • Adult
  • Philadelphia, Pennsylvania
    Group K Diagnostics
Jul 11, 2022

Chronic Hepatitis b, Liver Fibrosis Trial in Konya (Serum regucalcin level)

Completed
  • Chronic Hepatitis b
  • Liver Fibrosis
  • Serum regucalcin level
  • Konya, Turkey
    Konya Training and Research Hospital
Jun 23, 2022

Liver Fibrosis Trial in Taipei (Sildenafil 20 MG)

Recruiting
  • Liver Fibrosis
  • Sildenafil 20 MG
  • Taipei, Taiwan
    Department of Pediatrics, National Taiwan University Hospital
Jun 6, 2022

NAFLD, Alcohol-Related Disorder, Liver Fibrosis Trial in Angers (e-LIFT)

Completed
  • NAFLD
  • +2 more
  • e-LIFT
  • Angers, France
    Dr Adrien LANNES
May 11, 2022

Hepatic Cirrhosis, Liver Fibrosis, Nonalcoholic Fatty Liver Disease (NAFLD) Trial in Japan, United States (BMS-986036, Placebo)

Completed
  • Hepatic Cirrhosis
  • +3 more
  • Madison, Alabama
  • +90 more
May 9, 2022

Magnetic Resonance Elastography asMethod to Estimate Stiffness

Recruiting
  • Heart Failure
  • +3 more
    • Columbus, Ohio
      The Ohio State University Wexner Medical Center
    Apr 21, 2022

    Liver Fibrosis, Pediatric Disorder, Liver Transplant; Complications Trial in Shanghai (Liver Allograft Fibrosis by Using

    Not yet recruiting
    • Liver Fibrosis
    • +2 more
    • Liver Allograft Fibrosis by Using Fibrosis Panel(PRO-C3, PIIINP, TIMP-1, HA)
    • Shanghai, China
      Ren Ji Hospital, School of Medicine, Shanghai Jiao Tong Universi
    Apr 1, 2022

    Liver Fibrosis Trial in Beijing, Shanghai (Hydronidone capsules, The capsules)

    Recruiting
    • Liver Fibrosis
    • Hydronidone capsules
    • The placebo capsules
    • Beijing, Beijing, China
    • +1 more
    Mar 31, 2022

    Liver Fibrosis, FAP, Positron Emission Tomography Trial in Qingdao (18F-FAPI)

    Recruiting
    • Liver Fibrosis
    • +2 more
    • 18F-FAPI
    • Qingdao, Shandong, China
      The Affiliated Hospital of Qingdao University
    Feb 21, 2022

    Fluid Status on Liver Elastography and T1-mapping Results in

    Recruiting
    • NAFLD/MAFLD
    • +2 more
    • CMR
    • Vienna, Austria
      Medical University Vienna
    Feb 5, 2022

    Liver Fibrosis, Positron Emission Tomography, Magnetic Resonance Imaging Trial in Wuhan (PET/MR, PET/CT)

    Recruiting
    • Liver Fibrosis
    • +2 more
    • PET/MR
    • PET/CT
    • Wuhan, Hubei, China
      China, Hubei Province
    Feb 8, 2022

    Hepatic Cirrhosis, Liver Fibrosis Trial in San Antonio (BMS-986263, Placebo)

    Completed
    Has Results
    • Hepatic Cirrhosis
    • Liver Fibrosis
    • San Antonio, Texas
      The Texas Liver Institute
    Feb 3, 2022

    Liver Fibrosis Trial in Tehran (Imatinib 200mg, Placebo)

    Active, not recruiting
    • Liver Fibrosis
    • Imatinib 200mg
    • Placebo
    • Tehran, Iran, Islamic Republic of
      Research Institute of Gastroenterology & Liver Diseases
    Jan 24, 2022

    Liver Fibrosis, Pulmonary Fibrosis, Myocardial Fibrosis Trial in San Francisco (68Ga-FAP-2286, Positron Emission Tomography

    Recruiting
    • Liver Fibrosis
    • +2 more
    • San Francisco, California
      University of California, San Francisco
    Jan 5, 2022

    Rapid Breath-hold Quantitative Macromolecular Proton Fraction

    Recruiting
    • Liver Fibrosis
    • Magnetic Resonance Imaging
    • Hong Kong, Shatin, Hong Kong
      The Chinese University of Hong Kong, Prince of Wale Hospital
    Dec 9, 2021

    Liver Fibrosis Trial in Rochester (Mechanical Vibrations with Ultrasound Shear Wave Imaging)

    Completed
    Has Results
    • Liver Fibrosis
    • Mechanical Vibrations with Ultrasound Shear Wave Imaging
    • Rochester, Minnesota
      Mayo Clinic
    Dec 10, 2021

    Non-Alcoholic Fatty Liver Disease, Liver Fibrosis Trial in New Haven (PF-07202954 Repeat Dose, PF-07202954 Single Dose, Placebo)

    Completed
    • Non-Alcoholic Fatty Liver Disease
    • Liver Fibrosis
    • PF-07202954 Repeat Dose
    • +2 more
    • New Haven, Connecticut
      New Haven Clinical Research Unit
    Nov 11, 2021

    HIV-HBV Co-infected Patients in Southern Africa

    Completed
    • Hepatitis B Virus
    • +5 more
    • Standard of care
    • Lusaka, Zambia
      Centre for Infectious Disease Research in Zambia
    Nov 5, 2021

    Liver Fibrosis, Liver Steatosis Trial in Boston, Vancouver (Liver Incyte)

    Completed
    • Liver Fibrosis
    • Liver Steatosis
    • Liver Incyte
    • Boston, Massachusetts
    • +1 more
    Nov 4, 2021

    Liver Fibrosis Trial in France (Research FibroScan)

    Completed
    • Liver Fibrosis
    • Research FibroScan
    • Amiens, France
    • +5 more
    Oct 12, 2021

    Liver Fibrosis, Alcohol Abuse Trial (Simvastatin 40mg)

    Not yet recruiting
    • Liver Fibrosis
    • Alcohol Abuse
    • Simvastatin 40mg
    • (no location specified)
    Aug 30, 2021

    Development of Novel MRI Methods for Detecting, Discriminating,

    Recruiting
    • Liver Fibrosis
    • Non-Contrast Magnetic Resonance Imaging
    • Cincinnati, Ohio
      Cincinnati Children's Hospital Medical Center
    Jun 10, 2021

    Bariatric Endoscopy and NAFLD

    Recruiting
    • Obesity
    • +3 more
    • bariatric endoscopy, mainly intragastric balloons, plication of the stomach too
    • Ostrava, Moravian-Silesian Region, Czechia
      University Hospital Ostrava
    May 19, 2021

    Obesity, NAFLD, Liver Steatosis Trial in Ostrava (bariatric endoscopy, mainly intragastric baloons, plication of stomach too)

    Recruiting
    • Obesity
    • +3 more
    • bariatric endoscopy, mainly intragastric baloons, plication of stomach too
    • Ostrava, Czechia
      Department of gastroenterology, hepatology and pancreatology
    Dec 9, 2020

    Liver Fibrosis Trial in London (Warfarin)

    Completed
    Has Results
    • Liver Fibrosis
    • London, United Kingdom
      St Mary's Hospital NHS Trust
    Nov 6, 2020